MAP2K5 antibody (pSer311, pThr315)
Quick Overview for MAP2K5 antibody (pSer311, pThr315) (ABIN5688896)
Target
See all MAP2K5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer311, pThr315
-
Purification
- Affinity Purified
-
Immunogen
- Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser311, Thr315 of MEK5.
-
-
-
-
Application Notes
- The antibody has been directly tested for reactivity in Western blots with rat tissue. It is anticipated that the antibody will react with mouse, human, chicken, bovine, canine, non-human primate, Xenopus, and Zebrafish tissues based on the fact that these species have 100 % homology with the amino acid sequence used as antigen.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 100 μLin 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per mL BSA and 50 % glycerol.
-
Storage
- -20 °C
-
Storage Comment
- MEK5 antibody can be stored at -20°C and is stable at -20°C for at least 1 year.
-
-
- MAP2K5 (Mitogen-Activated Protein Kinase Kinase 5 (MAP2K5))
-
Alternative Name
- MEK5
-
Background
- MEK5 (also known as MKK5) is a dual specificity serine/threonine protein kinase belonging to the MAP kinase kinase family. MEK5 has been shown to specifically activate ERK5 (Zhou et al., 1995) whereas MEK5 itself is regulated by MEKK3 (Chao et al., 1999). An important link between MEK5 and metastatic prostrate cancer has been demonstrated (Mehta et.al., 2003). Dual phosphorylation of Ser311 and Thr315 have been implicated in cell proliferation (Cameron et al., 2004).
-
Molecular Weight
- 49 kDa
-
Gene ID
- 29568
-
UniProt
- Q62862
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway
Target
-